StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$2.56M. The highest annual figure on record is -$2.07M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.56M–
FY2024Dec 31, 2024-$2.07M–
FY2023Dec 31, 2023-$3.02M–
FY2022Dec 31, 2022-$15.48M–
FY2021Dec 31, 2021-$11.86M–
FY2020Dec 31, 2020-$2.30M–
FY2019Dec 31, 2019-$4.20M–
FY2018Dec 31, 2018-$3.45M–

More NewcelX figures

See a number that looks wrong?